Lipopolysaccharide-induced memory impairment in rats: a model of Alzheimer's disease
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu časopisecké články, přehledy
PubMed
28406691
DOI
10.33549/physiolres.933480
PII: 933480
Knihovny.cz E-zdroje
- MeSH
- Alzheimerova nemoc chemicky indukované metabolismus patologie MeSH
- krysa rodu Rattus MeSH
- lidé MeSH
- lipopolysacharidy toxicita MeSH
- mediátory zánětu metabolismus MeSH
- modely nemocí na zvířatech * MeSH
- poruchy paměti chemicky indukované metabolismus patologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- lipopolysacharidy MeSH
- mediátory zánětu MeSH
Alzheimer's disease (AD) is a primary cause of dementia in the middle-aged and elderly worldwide. Animal models for AD are widely used to study the disease mechanisms as well as to test potential therapeutic agents for disease modification. Among the non-genetically manipulated neuroinflammation models for AD, lipopolysaccharide (LPS)-induced animal model is commonly used. This review paper aims to discuss the possible factors that influence rats' response following LPS injection. Factors such as dose of LPS, route of administration, nature and duration of exposure as well as age and gender of animal used should be taken into account when designing a study using LPS-induced memory impairment as model for AD.
Citace poskytuje Crossref.org
Anti-inflammatory effect of Irisin on LPS-stimulated macrophages through inhibition of MAPK pathway